1.67 MONALEESA-7 and the Cost of Cancer Drugs with Dr. Stacie Dusetzina

OncologyMedicineHealth Policy
Written By Kerrington .

This week we begin the episode by discussing MONALEESA-7 and why ribociclib has been shown to increase overall survival while palbociclib has not. We finish the episode with an in-depth interview with Dr. Stacie Dusetzina of Vanderbilt University on her work in pharmacoeconomics, specifically we discuss her work on the market value of cancer drugs.

Kerrington .
Previous

1.68 Voxeletor with Dr. Olson & Humanizing Cancer, Defining Cancer, and more with Dr. David Steensma
Next

1.66 Employing Medical Writers & Frequentist vs Bayesian Methods with Dr. Allen Pannell